Skip to main content
. 2010 Aug 23;7(6):485–490. doi: 10.1038/cmi.2010.40

Table 1. Baseline characteristics of PBC patients.

Group (n) Sex (F/M) Age (years) ALT (U/l) AST (U/l) ALP (U/l) γ-GGT (U/l) TBil (umol/l) AMA (+/−) ANA (+/−)
Advanced (12) 11/1 51.0±9.5 115.5±114.2 130.5±110.9 479.8±325.7 669.5±424.9 66.6±72.4 10/2 9/3
Remission (9) 7/2 62.1±13.2 41.0±24.8 63.3±41.8 146.9±49.7* 110.4±86.5* 29.8±29.7 8/1 6/3

*P<0.01 versus patients with advanced stage PBC; values are mean±standard deviation. PBC patients were divided into two groups: advanced stage (ALP>2UNL, and γ-GGT>3UNL) and remission stage (ALP≤2UNL, and γ-GGT≤3UNL) of the disease.

Abbreviations: ALP, alkali phosphatase; ALT, alanine aminotransferase; AMA, antimitochondrial antibody; ANA, antinuclear antibody; AST, aspartate aminotransferase; PBC, primary biliary cirrhosis; TBil, total bilirubin; UNL, upper normal limit; γ-GGT, γ-glutamyltranspeptidase.